TD Cowen on Beta Bionics, Inc. (BBNX): 'our sense is the lift from here to address outstanding deficiencies is manageable'
Tweet Send to a Friend
TD Cowen analyst Michael Blackman reiterated a Hold rating and $17.00 price target on Beta Bionics, Inc. (NASDAQ: BBNX).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
